| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 16.40% |
| RVMD | REVOLUTION MEDICINES INC | 5.26% |
| PSNL | PERSONALIS | 3.65% |
| TVTX | TRAVERE THERAPEUTICS INC | 3.38% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 3.31% |
| EWTX | EDGEWISE THERAPEUTICS | 3.01% |
| HALO | HALOZYME THERAPEUTICS INC | 2.79% |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD. | 2.67% |
| IMVT | IMMUNOVANT INC | 2.21% |
| CYTK | CYTOKINETICS INC | 2.21% |
| GKOS | GLAUKOS CORPORATION | 2.13% |
| PCVX | VAXCYTE INC | 2.12% |
| HUM | HUMANA INC | 1.90% |
| TARS | TARSUS PHARMACEUTICALS | 1.82% |
| THC | TENET HEALTHCARE CORP | 1.81% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.75% |
| ABBV | ABBVIE INC | 1.69% |
| ARGX | ARGENX SE ADR | 1.65% |
| RGEN | REPLIGEN CORP | 1.61% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.58% |
| INSM | INSMED INC | 1.55% |
| DNLI | DENALI THERAPEUTICS INC. | 1.54% |
| ICLR | ICON PLC | 1.54% |
| MCK | MCKESSON CORP | 1.53% |
| UNH | UNITEDHEALTH GROUP INC | 1.53% |
| DYN | DYNE THERAPEUTICS, INC. | 1.51% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.50% |
| AZN | ASTRAZENECA PLC | 1.43% |
| DHR | DANAHER CORP | 1.38% |
| HCA | HCA HOLDINGS INC | 1.35% |
| ELV | ELEVANCE HEALTH INC | 1.25% |
| MDT | MEDTRONIC PLC | 1.25% |
| REGN | REGENERON PHARMACEUTICALS | 1.24% |
| BDX | BECTON DICKINSON & CO | 1.24% |
| RMD | RESMED INC | 1.15% |
| VCEL | VERICEL CORP | 1.14% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.11% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.07% |
| DXCM | DEXCOM INC | 1.03% |
| TNDM | TANDEM DIABETES CARE INC | 0.93% |
| SNY | SANOFI- AVENTIS- ADR | 0.91% |
| KRRO | KORRO BIO | 0.90% |
| ALC | ALCON INC | 0.89% |
| SYK | STRYKER CORP | 0.88% |
| ABT | ABBOTT LABORATORIES | 0.88% |
| ISRG | INTUITIVE SURGICAL INC | 0.86% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.69% |
| ADMA | ADMA BIOLOGICS, INC. | 0.64% |
| CDXS | CODEXIS INC | 0.60% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.56% |
| ZTS | ZOETIS INC | 0.55% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.51% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.50% |
| BSX | BOSTON SCIENTIFIC | 0.48% |
| WAT | WATERS CORP | 0.39% |
| SPRY | ARS PHARMACEUTICALS | 0.33% |
| LENZ | LENZ THERAPEUTICS | 0.13% |
| EYPT | EYEPOINT INC | 0.07% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) <a href="/services/prospectuses-and-reports">click here</a> or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.
